Ivan Tornos - 03 Dec 2022 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
Chief Operating Officer
Signature
Matthew St. Louis, Attorney-in-Fact for Ivan Tornos
Issuer symbol
ZBH
Transactions as of
03 Dec 2022
Transactions value $
-$219,004
Form type
4
Filing time
06 Dec 2022, 15:24:33 UTC
Previous filing
03 Mar 2022
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZBH Common Stock Options Exercise $0 +1,123 +8.5% $0 14,331 03 Dec 2022 Direct F1
transaction ZBH Common Stock Tax liability -$55,610 -453 -3.16% $122.76 13,878 03 Dec 2022 Direct F2
transaction ZBH Common Stock Options Exercise $0 +954 +6.87% $0 14,832 03 Dec 2022 Direct
transaction ZBH Common Stock Tax liability -$56,715 -462 -3.11% $122.76 14,370 03 Dec 2022 Direct F2
transaction ZBH Common Stock Options Exercise $0 +1,571 +10.93% $0 15,941 03 Dec 2022 Direct
transaction ZBH Common Stock Tax liability -$106,678 -869 -5.45% $122.76 15,072 03 Dec 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Restricted Stock Units Options Exercise $0 -1,123 -100% $0* 0 03 Dec 2022 Common Stock 1,123 Direct F3, F4
transaction ZBH Restricted Stock Units Options Exercise $0 -954 -100% $0* 0 03 Dec 2022 Common Stock 954 Direct F3, F4
transaction ZBH Restricted Stock Units Options Exercise $0 -1,571 -100% $0* 0 03 Dec 2022 Common Stock 1,571 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 203 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan since December 7, 2021.
F2 Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
F3 Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
F4 On December 3, 2018, the reporting person received three grants of RSUs that vested in increments of 25% each year, commencing December 3, 2019. In connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. on March 1, 2022, the remaining RSUs in the grants were adjusted to preserve the intrinsic value of such units by multiplying each RSU by an equity exchange ratio and rounded up to the nearest whole unit. The remaining 25% of the RSUs, as so adjusted, vested on December 3, 2022.